-
1
-
-
79952232216
-
Globalcancer statistics
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D.Globalcancer statistics. CA Cancer J Clin 2011;61:69-90.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
70749101076
-
Steroid hormone receptors in prostate cancer: A hard habit to break?
-
Attard G, Cooper CS, de Bono JS. Steroid hormone receptors in prostate cancer: a hard habit to break? Cancer Cell 2009;16:458-62.
-
(2009)
Cancer Cell
, vol.16
, pp. 458-462
-
-
Attard, G.1
Cooper, C.S.2
De Bono, J.S.3
-
4
-
-
84861581164
-
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
-
Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theur-illat JP, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012;44:685-9.
-
(2012)
Nat Genet
, vol.44
, pp. 685-689
-
-
Barbieri, C.E.1
Baca, S.C.2
Lawrence, M.S.3
Demichelis, F.4
Blattner, M.5
Theur-Illat, J.P.6
-
5
-
-
84863723010
-
The mutational landscape of lethal castration-resistant prostate cancer
-
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012;487:239-43.
-
(2012)
Nature
, vol.487
, pp. 239-243
-
-
Grasso, C.S.1
Wu, Y.M.2
Robinson, D.R.3
Cao, X.4
Dhanasekaran, S.M.5
Khan, A.P.6
-
6
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010;18:11-22.
-
(2010)
Cancer Cell
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
Schultz, N.2
Hieronymus, H.3
Gopalan, A.4
Xiao, Y.5
Carver, B.S.6
-
7
-
-
84975685847
-
From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer
-
Lapuk AV, Wu C, Wyatt AW, McPherson A, McConeghy BJ, Brahmb-hatt S, et al. From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer. J Pathol 2012;227:286-97.
-
(2012)
J Pathol
, vol.227
, pp. 286-297
-
-
Lapuk, A.V.1
Wu, C.2
Wyatt, A.W.3
McPherson, A.4
McConeghy, B.J.5
Brahmb-Hatt, S.6
-
8
-
-
2042458747
-
Relationships between drug activity in NCI preclin-ical in vitro and in vivo models and early clinical trials
-
Johnson JI, Decker S, Zaharevitz D, Rubinstein LV, Venditti JM, Schepartz S, et al. Relationships between drug activity in NCI preclin-ical in vitro and in vivo models and early clinical trials. Br J Cancer 2001;84:1424-31.
-
(2001)
Br J Cancer
, vol.84
, pp. 1424-1431
-
-
Johnson, J.I.1
Decker, S.2
Zaharevitz, D.3
Rubinstein, L.V.4
Venditti, J.M.5
Schepartz, S.6
-
9
-
-
33748331308
-
The mighty mouse: Genetically engineered mouse models in cancer drug development
-
Sharpless NE, Depinho RA. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov 2006;5:741-54.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 741-754
-
-
Sharpless, N.E.1
Depinho, R.A.2
-
10
-
-
33846995628
-
Economics of new oncology drug development
-
DiMasi JA, Grabowski HG. Economics of new oncology drug development. J Clin Oncol 2007;25:209-16.
-
(2007)
J Clin Oncol
, vol.25
, pp. 209-216
-
-
Dimasi, J.A.1
Grabowski, H.G.2
-
11
-
-
58749103524
-
From human to mouse and back: 'Tumorgraft' models surge in popularity
-
Garber K. From human to mouse and back: 'tumorgraft' models surge in popularity. J Natl Cancer Inst 2009;101:6-8.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 6-8
-
-
Garber, K.1
-
12
-
-
0029745683
-
Development of seven new human prostate tumor xenograft models and their histopathological characterization
-
van Weerden WM, de Ridder CM, Verdaasdonk CL, Romijn JC, van der Kwast TH, Schroder FH, et al. Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 1996;149:1055-62.
-
(1996)
Am J Pathol
, vol.149
, pp. 1055-1062
-
-
Van Weerden, W.M.1
De Ridder, C.M.2
Verdaasdonk, C.L.3
Romijn, J.C.4
Van Der Kwast, T.H.5
Schroder, F.H.6
-
13
-
-
16944366096
-
Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice
-
Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997;3:402-8.
-
(1997)
Nat Med
, vol.3
, pp. 402-408
-
-
Klein, K.A.1
Reiter, R.E.2
Redula, J.3
Moradi, H.4
Zhu, X.L.5
Brothman, A.R.6
-
14
-
-
84894247282
-
Xenograft Models of Human Prostate Cancer
-
Leland W.K., Chung WBI, Jonathan W. Simons, editors, Totawa: Humana Press Inc.;
-
Eva Corey RLV. Xenograft Models of Human Prostate Cancer. In: Leland W.K., Chung WBI, Jonathan W. Simons, editors. Contemporary Cancer Research: Prostate Cancer: Biology, Genetics, and the New Therapeutics. 2nd ed. Totawa: Humana Press Inc.; 2007.
-
(2007)
Contemporary Cancer Research: Prostate Cancer: Biology, Genetics, and the New Therapeutics. 2nd Ed
-
-
Eva Corey, R.L.V.1
-
15
-
-
0035881285
-
A human prostatic epithelial model of hormonal carcinogenesis
-
Wang Y, Sudilovsky D, Zhang B, Haughney PC, Rosen MA, Wu DS, et al. A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res 2001;61:6064-72.
-
(2001)
Cancer Res
, vol.61
, pp. 6064-6072
-
-
Wang, Y.1
Sudilovsky, D.2
Zhang, B.3
Haughney, P.C.4
Rosen, M.A.5
Wu, D.S.6
-
16
-
-
58549118535
-
Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients
-
Rubio-Viqueira B, Hidalgo M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clin Pharmacol Ther 2009;85:217-21.
-
(2009)
Clin Pharmacol Ther
, vol.85
, pp. 217-221
-
-
Rubio-Viqueira, B.1
Hidalgo, M.2
-
17
-
-
0037441315
-
Quantitation of apoptotic activity following castration in human pros-tatic tissue in vivo
-
Staack A, Kassis AP, Olshen A, Wang Y, Wu D, Carroll PR, et al. Quantitation of apoptotic activity following castration in human pros-tatic tissue in vivo. Prostate 2003;54:212-9.
-
(2003)
Prostate
, vol.54
, pp. 212-219
-
-
Staack, A.1
Kassis, A.P.2
Olshen, A.3
Wang, Y.4
Wu, D.5
Carroll, P.R.6
-
18
-
-
20344361938
-
Development and characterization of efficient xenograft models for benign and malignant human prostate tissue
-
Wang Y, Revelo MP, Sudilovsky D, Cao M, Chen WG, Goetz L, et al. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate 2005;64: 149-59.
-
(2005)
Prostate
, vol.64
, pp. 149-159
-
-
Wang, Y.1
Revelo, M.P.2
Sudilovsky, D.3
Cao, M.4
Chen, W.G.5
Goetz, L.6
-
19
-
-
84877047730
-
A preclinical xenograft model of prostate cancer using human tumors
-
Lawrence MG, Taylor RA, Toivanen R, Pedersen J, Norden S, Pook DW, et al. A preclinical xenograft model of prostate cancer using human tumors. Nat Protoc 2013;8:836-48.
-
(2013)
Nat Protoc
, vol.8
, pp. 836-848
-
-
Lawrence, M.G.1
Taylor, R.A.2
Toivanen, R.3
Pedersen, J.4
Norden, S.5
Pook, D.W.6
-
20
-
-
84880560009
-
A preclinical xenograft model identifies castration-tolerant can-cer-repopulating cells in localized prostate tumors
-
Toivanen R, Frydenberg M, Murphy D, Pedersen J, Ryan A, Pook D, et al. A preclinical xenograft model identifies castration-tolerant can-cer-repopulating cells in localized prostate tumors. Sci Transl Med 2013;5:187ra71.
-
(2013)
Sci Transl Med
, vol.5
-
-
Toivanen, R.1
Frydenberg, M.2
Murphy, D.3
Pedersen, J.4
Ryan, A.5
Pook, D.6
-
21
-
-
49249106186
-
ASAP1, a gene at 8q24, is associated with prostate cancer metastasis
-
Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, et al. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res 2008;68:4352-9.
-
(2008)
Cancer Res
, vol.68
, pp. 4352-4359
-
-
Lin, D.1
Watahiki, A.2
Bayani, J.3
Zhang, F.4
Liu, L.5
Ling, V.6
-
22
-
-
84975810758
-
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer
-
Wu C, Wyatt AW, Lapuk AV, McPherson A, McConeghy BJ, Bell RH, et al. Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer. J Pathol 2012; 227:53-61.
-
(2012)
J Pathol
, vol.227
, pp. 53-61
-
-
Wu, C.1
Wyatt, A.W.2
Lapuk, A.V.3
McPherson, A.4
McConeghy, B.J.5
Bell, R.H.6
-
23
-
-
61449172037
-
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
-
Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
-
(2009)
Nat Protoc
, vol.4
, pp. 44-57
-
-
Huang Da, W.1
Sherman, B.T.2
Lempicki, R.A.3
-
24
-
-
84860168795
-
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
-
Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, et al. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov 2011;1: 487-95.
-
(2011)
Cancer Discov
, vol.1
, pp. 487-495
-
-
Beltran, H.1
Rickman, D.S.2
Park, K.3
Chae, S.S.4
Sboner, A.5
Macdonald, T.Y.6
-
25
-
-
84868332770
-
NFuse: Discovery of complex genomic rearrangements in cancer using high-throughput sequencing
-
McPherson A, Wu C, Wyatt AW, Shah S, Collins C, Sahinalp SC.nFuse: discovery of complex genomic rearrangements in cancer using high-throughput sequencing. Genome Res 2012;22:2250-61.
-
(2012)
Genome Res
, vol.22
, pp. 2250-2261
-
-
McPherson, A.1
Wu, C.2
Wyatt, A.W.3
Shah, S.4
Collins, C.5
Sahinalp, S.C.6
-
26
-
-
0026053945
-
Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man
-
Rowe M, Young LS, Crocker J, Stokes H, Henderson S, Rickinson AB. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man. J Exp Med 1991;173:147-58.
-
(1991)
J Exp Med
, vol.173
, pp. 147-158
-
-
Rowe, M.1
Young, L.S.2
Crocker, J.3
Stokes, H.4
Henderson, S.5
Rickinson, A.B.6
-
27
-
-
33846479832
-
Unusual and underappreciated: Small cell carcinoma of the prostate
-
Palmgren JS, Karavadia SS, Wakefield MR. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 2007;34: 22-9.
-
(2007)
Semin Oncol
, vol.34
, pp. 22-29
-
-
Palmgren, J.S.1
Karavadia, S.S.2
Wakefield, M.R.3
-
28
-
-
79951497419
-
The genomic complexity of primary human prostate cancer
-
Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Siva-chenko AY, et al. The genomic complexity of primary human prostate cancer. Nature 2011;470:214-20.
-
(2011)
Nature
, vol.470
, pp. 214-220
-
-
Berger, M.F.1
Lawrence, M.S.2
Demichelis, F.3
Drier, Y.4
Cibulskis, K.5
Siva-Chenko, A.Y.6
-
29
-
-
33644653015
-
Decoding the fine-scale structure of a breast cancer genome and transcriptome
-
Volik S, Raphael BJ, Huang G, Stratton MR, Bignel G, Murnane J, et al. Decoding the fine-scale structure of a breast cancer genome and transcriptome. Genome Res 2006;16:394-404.
-
(2006)
Genome Res
, vol.16
, pp. 394-404
-
-
Volik, S.1
Raphael, B.J.2
Huang, G.3
Stratton, M.R.4
Bignel, G.5
Murnane, J.6
-
30
-
-
43249096825
-
A sequence-based survey of the complex structural organization of tumor genomes
-
Raphael BJ, Volik S, Yu P, Wu C, Huang G, Linardopoulou EV, et al. A sequence-based survey of the complex structural organization of tumor genomes. Genome Biol 2008;9:R59.
-
(2008)
Genome Biol
, vol.9
-
-
Raphael, B.J.1
Volik, S.2
Yu, P.3
Wu, C.4
Huang, G.5
Linardopoulou, E.V.6
-
31
-
-
84856530618
-
Common structural and epigenetic changes in the genome of castration-resistant prostate cancer
-
Friedlander TW, Roy R, Tomlins SA, Ngo VT, Kobayashi Y, Azameera A, et al. Common structural and epigenetic changes in the genome of castration-resistant prostate cancer. Cancer Res 2012;72:616-25.
-
(2012)
Cancer Res
, vol.72
, pp. 616-625
-
-
Friedlander, T.W.1
Roy, R.2
Tomlins, S.A.3
Ngo, V.T.4
Kobayashi, Y.5
Azameera, A.6
-
32
-
-
27344451557
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
-
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-8.
-
(2005)
Science
, vol.310
, pp. 644-648
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Perner, S.3
Dhanasekaran, S.M.4
Mehra, R.5
Sun, X.W.6
-
33
-
-
34447342868
-
TMPRSS2-ERG fusion prostate cancer: An early molecular event associated with invasion
-
Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007;31:882-8.
-
(2007)
Am J Surg Pathol
, vol.31
, pp. 882-888
-
-
Perner, S.1
Mosquera, J.M.2
Demichelis, F.3
Hofer, M.D.4
Paris, P.L.5
Simko, J.6
-
34
-
-
66749188650
-
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
-
Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 2009;41:619-24.
-
(2009)
Nat Genet
, vol.41
, pp. 619-624
-
-
Carver, B.S.1
Tran, J.2
Gopalan, A.3
Chen, Z.4
Shaikh, S.5
Carracedo, A.6
-
35
-
-
33847666377
-
Clinical implications of neuroendocrine differentiation in prostate cancer
-
Nelson EC, Cambio AJ, Yang JC, Ok JH, Lara PN Jr, Evans CP. Clinical implications of neuroendocrine differentiation in prostate cancer. Prostate Cancer Prostatic Dis 2007;10:6-14.
-
(2007)
Prostate Cancer Prostatic Dis
, vol.10
, pp. 6-14
-
-
Nelson, E.C.1
Cambio, A.J.2
Yang, J.C.3
Ok, J.H.4
Lara Jr., P.N.5
Evans, C.P.6
-
36
-
-
79961031503
-
ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: Evidence supporting monoclonal origin
-
Williamson SR, Zhang S, Yao JL, Huang J, Lopez-Beltran A, Shen S, et al. ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol 2011;24:1120-7.
-
(2011)
Mod Pathol
, vol.24
, pp. 1120-1127
-
-
Williamson, S.R.1
Zhang, S.2
Yao, J.L.3
Huang, J.4
Lopez-Beltran, A.5
Shen, S.6
-
37
-
-
79957912763
-
ERG gene rearrangements are common in prostatic small cell carcinomas
-
Lotan TL, Gupta NS, Wang W, Toubaji A, Haffner MC, Chaux A, et al. ERG gene rearrangements are common in prostatic small cell carcinomas. Mod Pathol 2011;24:820-8.
-
(2011)
Mod Pathol
, vol.24
, pp. 820-828
-
-
Lotan, T.L.1
Gupta, N.S.2
Wang, W.3
Toubaji, A.4
Haffner, M.C.5
Chaux, A.6
-
38
-
-
77950592442
-
Establishment and genomic characterization of mouse xenografts of human primary prostate tumors
-
Priolo C, Agostini M, Vena N, Ligon AH, Fiorentino M, Shin E, et al. Establishment and genomic characterization of mouse xenografts of human primary prostate tumors. Am J Pathol 2010;176:1901-13.
-
(2010)
Am J Pathol
, vol.176
, pp. 1901-1913
-
-
Priolo, C.1
Agostini, M.2
Vena, N.3
Ligon, A.H.4
Fiorentino, M.5
Shin, E.6
-
39
-
-
77954582489
-
Tissue slice grafts: An in vivo model of human prostate androgen signaling
-
Zhao H, Nolley R, Chen Z, Peehl DM. Tissue slice grafts: an in vivo model of human prostate androgen signaling. Am J Pathol 2010; 177:229-39.
-
(2010)
Am J Pathol
, vol.177
, pp. 229-239
-
-
Zhao, H.1
Nolley, R.2
Chen, Z.3
Peehl, D.M.4
-
40
-
-
0017158894
-
Tissue pressures and fluid dynamics in the kidney
-
Ott CE, Knox FG. Tissue pressures and fluid dynamics in the kidney. Fed Proc 1976;35:1872-5.
-
(1976)
Fed Proc
, vol.35
, pp. 1872-1875
-
-
Ott, C.E.1
Knox, F.G.2
-
41
-
-
8944223083
-
Renal lymph: Vital for the kidney and valuable for the physiologist
-
Pinter G. Renal lymph: vital for the kidney and valuable for the physiologist. Physiology 1988;3:189-93.
-
(1988)
Physiology
, vol.3
, pp. 189-193
-
-
Pinter, G.1
-
42
-
-
0032708879
-
Early events in the formation of a tissue structure from dispersed bovine adrenocortical cells following transplantation into scid mice
-
Tunstead JR, Thomas M, Hornsby PJ. Early events in the formation of a tissue structure from dispersed bovine adrenocortical cells following transplantation into scid mice. J Mol Med 1999;77:666-76.
-
(1999)
J Mol Med
, vol.77
, pp. 666-676
-
-
Tunstead, J.R.1
Thomas, M.2
Hornsby, P.J.3
-
43
-
-
0017146252
-
Epithelial-stromal interactions in development of the uro-genital tract
-
Cunha GR. Epithelial-stromal interactions in development of the uro-genital tract. Int Rev Cytol 1976;47:137-94.
-
(1976)
Int Rev Cytol
, vol.47
, pp. 137-194
-
-
Cunha, G.R.1
-
44
-
-
0021021278
-
Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy
-
Griffin TW, Bogden AE, Reich SD, Antonelli D, Hunter RE, Ward A, et al. Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer 1983;52:2185-92.
-
(1983)
Cancer
, vol.52
, pp. 2185-2192
-
-
Griffin, T.W.1
Bogden, A.E.2
Reich, S.D.3
Antonelli, D.4
Hunter, R.E.5
Ward, A.6
-
45
-
-
0033561535
-
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
-
Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 1999;59:1987-93.
-
(1999)
Cancer Res
, vol.59
, pp. 1987-1993
-
-
Nemeth, J.A.1
Harb, J.F.2
Barroso Jr., U.3
He, Z.4
Grignon, D.J.5
Cher, M.L.6
-
46
-
-
0035266413
-
Establishment of a novel species-and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone
-
Yonou H, Yokose T, Kamijo T, Kanomata N, Hasebe T, Nagai K, et al. Establishment of a novel species-and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 2001;61:2177-82.
-
(2001)
Cancer Res
, vol.61
, pp. 2177-2182
-
-
Yonou, H.1
Yokose, T.2
Kamijo, T.3
Kanomata, N.4
Hasebe, T.5
Nagai, K.6
-
47
-
-
67349257845
-
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
-
Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009;15:559-65.
-
(2009)
Nat Med
, vol.15
, pp. 559-565
-
-
Liu, W.1
Laitinen, S.2
Khan, S.3
Vihinen, M.4
Kowalski, J.5
Yu, G.6
-
48
-
-
80053584635
-
MicroRNAs associated with metastatic prostate cancer
-
Watahiki A, Wang Y, Morris J, Dennis K, O'Dwyer HM, Gleave M, et al. MicroRNAs associated with metastatic prostate cancer. PLoS ONE 2011;6:e24950.
-
(2011)
PLoS ONE
, vol.6
-
-
Watahiki, A.1
Wang, Y.2
Morris, J.3
Dennis, K.4
O'Dwyer, H.M.5
Gleave, M.6
-
49
-
-
81255135837
-
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
-
DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med 2011;17:1514-20.
-
(2011)
Nat Med
, vol.17
, pp. 1514-1520
-
-
Derose, Y.S.1
Wang, G.2
Lin, Y.C.3
Bernard, P.S.4
Buys, S.S.5
Ebbert, M.T.6
-
50
-
-
33746068275
-
Establishment in severe combined immunodeficiency mice of sub-renal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: Potential models for studying tumor progression-related changes
-
Cutz JC, Guan J, Bayani J, Yoshimoto M, Xue H, Sutcliffe M, et al. Establishment in severe combined immunodeficiency mice of sub-renal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changes. Clin Cancer Res 2006;12: 4043-54.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 4043-4054
-
-
Cutz, J.C.1
Guan, J.2
Bayani, J.3
Yoshimoto, M.4
Xue, H.5
Sutcliffe, M.6
-
51
-
-
84863013857
-
Modeling a lethal prostate cancer variant with small-cell carcinoma features
-
Tzelepi V, Zhang J, Lu JF, Kleb B, Wu G, Wan X, et al. Modeling a lethal prostate cancer variant with small-cell carcinoma features. Clin Cancer Res 2012;18:666-77.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 666-677
-
-
Tzelepi, V.1
Zhang, J.2
Lu, J.F.3
Kleb, B.4
Wu, G.5
Wan, X.6
-
52
-
-
84866770294
-
Increased survival with enzalutamide in prostate cancer after chemotherapy
-
Scher HI, Fizazi K, Saad F, Taplin ME, Sternberg CN, Miller K, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 2012;367:1187-97.
-
(2012)
N Engl J Med
, vol.367
, pp. 1187-1197
-
-
Scher, H.I.1
Fizazi, K.2
Saad, F.3
Taplin, M.E.4
Sternberg, C.N.5
Miller, K.6
-
53
-
-
84866948935
-
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: Final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
-
Fizazi K, Scher HI, Molina A, Logothetis CJ, Chi KN, Jones RJ, et al. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol 2012;13:983-92.
-
(2012)
Lancet Oncol
, vol.13
, pp. 983-992
-
-
Fizazi, K.1
Scher, H.I.2
Molina, A.3
Logothetis, C.J.4
Chi, K.N.5
Jones, R.J.6
-
54
-
-
77649178137
-
Patient-derived first generation xenografts of non-small cell lung cancers: Promising tools for predicting drug responses for personalized chemotherapy
-
Dong X, Guan J, English JC, Flint J, Yee J, Evans K, et al. Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy. Clin Cancer Res 2010;16:1442-51.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 1442-1451
-
-
Dong, X.1
Guan, J.2
English, J.C.3
Flint, J.4
Yee, J.5
Evans, K.6
-
55
-
-
79951819983
-
Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts
-
Kortmann U, McAlpine JN, Xue H, Guan J, Ha G, Tully S, et al. Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts. Clin Cancer Res 2011;17: 783-91.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 783-791
-
-
Kortmann, U.1
McAlpine, J.N.2
Xue, H.3
Guan, J.4
Ha, G.5
Tully, S.6
-
56
-
-
84859414102
-
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target
-
Collins CC, Volik SV, Lapuk AV, Wang Y, Gout PW, Wu C, et al. Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target. Mol Cancer Ther 2012;11:775-83.
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 775-783
-
-
Collins, C.C.1
Volik, S.V.2
Lapuk, A.V.3
Wang, Y.4
Gout, P.W.5
Wu, C.6
-
57
-
-
77953280591
-
Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor
-
Andersen RJ, Mawji NR, Wang J, Wang G, Haile S, Myung JK, et al. Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell 2010;17:535-46.
-
(2010)
Cancer Cell
, vol.17
, pp. 535-546
-
-
Andersen, R.J.1
Mawji, N.R.2
Wang, J.3
Wang, G.4
Haile, S.5
Myung, J.K.6
|